News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TetraPhase Pharmaceuticals To Present Data On Advancing Product Pipeline At 24th ECCMID



5/12/2014 6:59:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the upcoming presentation of six scientific posters at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) taking place May 10-13, 2014 in Barcelona, Spain.

“Eravacycline Protects in a Bacillus anthracis-Infected New Zealand White Rabbit Treatment Model” “We are excited to be presenting data on multiple antibiotic candidates at ECCMID this year,” said Guy Macdonald, President and CEO of Tetraphase.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES